COVID-19 vaccine weekly safety report (27 January 2022)

27 January 2022 - To 23 January 2022, the TGA has received 431 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine weekly safety report (20 January 2022)

20 January 2022 - To 16 January 2022, the TGA has received 428 reports which have been assessed as likely to ...

Read more →

TGA ‘knowingly putting pharmacists in serious danger’

18 January 2022 - The pharmacists’ union has accused the medical regulator of putting workers and customers at risk of ...

Read more →

COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy

18 January 2022 - Vaccination remains a major pillar of the response to COVID-19, particularly as variants of the virus continue ...

Read more →

COVID-19 vaccine weekly safety report (13 January 2022)

13 January 2022 - To 9 January 2022, the TGA has received 952 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine weekly safety report (6 January 2022)

17 January 2022 - To 2 January 2022, the TGA has received 415 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine weekly safety report (23 December 2021)

23 December 2021 - To 19 December 2021, the TGA has received 415 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine weekly safety report (16 December 2021)

16 December 2021 - To 12 December 2021, the TGA has received approximately 290 reports of suspected adverse events identified as ...

Read more →

COVID-19 vaccine weekly safety report (9 December 2021)

9 December 2021 - To 5 December 2021, the TGA has received 389 reports which have been assessed as likely to ...

Read more →

AbbVie provides update on Rinvoq (upadacitinib) for the treatment of rheumatoid arthritis in the U.S.

3 December 2021 - AbbVie today announced an update to the U.S. Prescribing Information and Medication Guide for Rinvoq (upadacitinib) for ...

Read more →

ATAGI update following weekly COVID-19 meeting (1 December 2021)

3 December 2021 - On  1 December 2021 ATAGI reviewed the latest developments relating to COVID-19 and COVID-19 vaccine safety.  ...

Read more →

COVID-19 vaccine weekly safety report (2 December 2021)

2 December 2021 - To 28 November 2021, the TGA has received 354 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine weekly safety report (25 November 2021)

25 November 2021 - To 21 November 2021, the TGA has received 341 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine indemnity

24 November 2021 - The Australian Government is reducing the claim threshold of the no fault COVID-19 Vaccine Claims Scheme to ...

Read more →

COVID-19 vaccine weekly safety report (18 November 2021)

18 November 2021 - To 14 November 2021, about 23.4 million doses of Comirnaty (Pfizer) have been administered in Australia. ...

Read more →